Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune therapy for human papillomaviruses-related cancers
Ricardo Rosales
World Journal of Clinical Oncology (2014) Vol. 5, Iss. 5, pp. 1002-1002
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
Benjamin Kansy, Fernando Concha‐Benavente, Raghvendra M. Srivastava, et al.
Cancer Research (2017) Vol. 77, Iss. 22, pp. 6353-6364
Open Access | Times Cited: 203
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System
Chenhao Zhou, Zewen Kelvin Tuong, Ian H. Frazer
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 183
Human Papillomavirus Vaccines
Lauri E. Markowitz, John T. Schiller
The Journal of Infectious Diseases (2021) Vol. 224, Iss. Supplement_4, pp. S367-S378
Open Access | Times Cited: 106
Regression of Human Papillomavirus Intraepithelial Lesions Is Induced by MVA E2 Therapeutic Vaccine
Ricardo Rosales, Mario López‐Contreras, Carlos Rosales, et al.
Human Gene Therapy (2014) Vol. 25, Iss. 12, pp. 1035-1049
Open Access | Times Cited: 122
Current state in the development of candidate therapeutic HPV vaccines
Andrew Yang, Jessica Jeang, Yeu-Yao Cheng, et al.
Expert Review of Vaccines (2016) Vol. 15, Iss. 8, pp. 989-1007
Open Access | Times Cited: 110
Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers
Maryam Soheili, Hossein Keyvani, Marzieh Soheili, et al.
Medical Journal of the Islamic Republic of Iran (2021)
Open Access | Times Cited: 79
Tracking HPV Infection, Associated Cancer Development, and Recent Treatment Efforts—A Comprehensive Review
Shiza Malik, Ranjit Sah, Khalid Muhammad, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 102-102
Open Access | Times Cited: 32
HPV Infections—Classification, Pathogenesis, and Potential New Therapies
Beata Mlynarczyk-Bonikowska, Lidia Rudnicka
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7616-7616
Open Access | Times Cited: 14
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
Antônio Carlos de Freitas, Talita Helena Araújo de Oliveira, Marconi Rêgo Barros Júnior, et al.
Journal of Experimental & Clinical Cancer Research (2017) Vol. 36, Iss. 1
Open Access | Times Cited: 81
HPV Prophylactic Vaccination in Males Improves the Clearance of Semen Infection
Carlo Foresta, Andrea Garolla, Saverio Giuseppe Parisi, et al.
EBioMedicine (2015) Vol. 2, Iss. 10, pp. 1487-1493
Open Access | Times Cited: 43
Unraveling HPV-Associated cancer complexity: From molecular insights to innovative therapies
Tara Chand, Ashwini Kumar Dubey, Gauri Misra
Heliyon (2025) Vol. 11, Iss. 3, pp. e42437-e42437
Open Access
Regulation of Granzymes A and B by High-Risk HPV: Impact on Immune Evasion and Carcinogenesis
Mashego Nathan Maleka, Zukile Mbita, Vivian Morafo
Viruses (2025) Vol. 17, Iss. 2, pp. 221-221
Open Access
Overview of genetic and epigenetic regulation of human papillomavirus and apoptosis in cervical cancer
Chetna Yadav, Ritu Yadav, Ravindresh Chabbra, et al.
APOPTOSIS (2023) Vol. 28, Iss. 5-6, pp. 683-701
Closed Access | Times Cited: 9
Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells
Sanaz Baghban Rahimi, Alireza Mohebbi, Gelareh Vakilzadeh, et al.
Archives of Virology (2017) Vol. 163, Iss. 3, pp. 587-597
Closed Access | Times Cited: 33
HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities
George Krashias, Dana Koptides, Christina Christodoulou
BMC Infectious Diseases (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 31
Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan
Arwa Qaqish, Nour Abdo, Manal M. Abbas, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0291643-e0291643
Open Access | Times Cited: 8
An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia
Lynne Hampson, Pierre L. Martin‐Hirsch, Ian Hampson
Expert Opinion on Investigational Drugs (2015) Vol. 24, Iss. 12, pp. 1529-1537
Open Access | Times Cited: 28
Human Papilloma Virus Infection Does Not Predict Response to Interferon Therapy in Ocular Surface Squamous Neoplasia
Anat Galor, Nisha Garg, Afshan Nanji, et al.
Ophthalmology (2015) Vol. 122, Iss. 11, pp. 2210-2215
Open Access | Times Cited: 25
Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay
Märt Toots, Mart Ustav, Andres Männik, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 2, pp. e1006168-e1006168
Open Access | Times Cited: 25
Co‐administration of 2’3’-cGAMP STING activator and CpG-C adjuvants with a mutated form of HPV 16 E7 protein leads to tumor growth inhibition in the mouse model
Fariba Dorostkar, Arash Arashkia, Farzin Roohvand, et al.
Infectious Agents and Cancer (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 19
Natural and synthetic drugs and formulations for intravaginal HPV clearance
Nizar A. Khamjan, Saba Beigh, Abdullah Algaissi, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 9, pp. 1471-1480
Open Access | Times Cited: 7
Immunotherapy of viral warts: myth and reality
Mohamed El‐Khalawany, Dalia Shaaban, Mohammed Abu El‐Hamd
Egyptian Journal of Dermatology and Venerology (2015) Vol. 35, Iss. 1, pp. 1-1
Closed Access | Times Cited: 24
Symptomatic Improvement in Human Papillomavirus-Induced Epithelial Neoplasia by Specific Targeting of the CXCR4 Chemokine Receptor
Floriane Meuris, Françoise Gaudin, Marie-Laure Aknin, et al.
Journal of Investigative Dermatology (2015) Vol. 136, Iss. 2, pp. 473-480
Open Access | Times Cited: 19
The Immune Response Generated against HPV Infection in Men and Its Implications in the Diagnosis of Cancer
Lilia Chihu-Amparán, Adolfo Pedroza-Saavedra, Lourdes Gutiérrez‐Xicoténcatl
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1609-1609
Open Access | Times Cited: 6
MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis
Olga Rodriguez Cabo Beltran, Ricardo Rosales Ledezma
Head & Neck (2019) Vol. 41, Iss. 3, pp. 657-665
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top